Médicaments myélotoxicques

dc.contributor.advisorA. Belmekki
dc.contributor.authorAbdelhadi Rachidi
dc.date.accessioned2023-09-15T13:37:56Z
dc.date.accessioned2026-01-22T13:32:08Z
dc.date.available2023-09-15T13:37:56Z
dc.date.issued2011
dc.description.collaboratorA. Belmekki
dc.description.collaboratorN. Messaoudi
dc.description.collaboratorM. Rabih
dc.description.collaboratorS. Mrani
dc.description.collaboratorM. Chakkour
dc.identifier.urihttps://toubkal.imist.ma/handle/123456789/18666
dc.identifier.urihttps://doi.org/10.83129/toubkal-13479
dc.language.isofr
dc.publisherUniversité Mohammed 5 de Rabat, Faculté de Médecine et de Pharmacie, Rabatfr_FR
dc.subjectHématopoiesefr_FR
dc.subjectmyélotoxicitéfr_FR
dc.subjectcytopéniefr_FR
dc.subject.otherSciences médicales
dc.subject.specificThérapeutique
dc.titleMédicaments myélotoxicquesfr_FR

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
P0732011.pdf
Size:
4.49 MB
Format:
Adobe Portable Document Format